Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study

J. Wolf; E. B. Garon; H. J.M. Groen; D. S.W. Tan; S. Le Mouhaer; M. Riester; L. Ji; A. Robeva; L. Fairchild; A. Boran; R. S. Heist

doi:10.1016/S0959-8049(22)00859-0

Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study

J. Wolf, E. B. Garon, H. J.M. Groen, D. S.W. Tan, S. Le Mouhaer, M. Riester, L. Ji, A. Robeva, L. Fairchild, A. Boran, R. S. Heist

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	S21
Aantal pagina's	1
Tijdschrift	European Journal of Cancer
Volume	174
DOI's	https://doi.org/10.1016/S0959-8049(22)00859-0
Status	Published - okt.-2022

Toegang tot document

10.1016/S0959-8049(22)00859-0

Handle.net

Permanente koppeling

Citeer dit

Wolf, J., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Le Mouhaer, S., Riester, M., Ji, L., Robeva, A., Fairchild, L., Boran, A., & Heist, R. S. (2022). Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study. European Journal of Cancer, 174, S21. https://doi.org/10.1016/S0959-8049(22)00859-0

@article{8282646c81d74cddbd7d2cfa720270ae,

title = "Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study",

author = "J. Wolf and Garon, {E. B.} and Groen, {H. J.M.} and Tan, {D. S.W.} and {Le Mouhaer}, S. and M. Riester and L. Ji and A. Robeva and L. Fairchild and A. Boran and Heist, {R. S.}",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00859-0",

language = "English",

volume = "174",

pages = "S21",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "ELSEVIER SCI LTD",

}

Wolf, J, Garon, EB, Groen, HJM, Tan, DSW, Le Mouhaer, S, Riester, M, Ji, L, Robeva, A, Fairchild, L, Boran, A & Heist, RS 2022, 'Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study', European Journal of Cancer, vol. 174, blz. S21. https://doi.org/10.1016/S0959-8049(22)00859-0

TY - JOUR

T1 - Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications

T2 - Analysis from the phase 2, multicohort GEOMETRY mono-1 study

AU - Wolf, J.

AU - Garon, E. B.

AU - Groen, H. J.M.

AU - Tan, D. S.W.

AU - Le Mouhaer, S.

AU - Riester, M.

AU - Ji, L.

AU - Robeva, A.

AU - Fairchild, L.

AU - Boran, A.

AU - Heist, R. S.

PY - 2022/10

Y1 - 2022/10

U2 - 10.1016/S0959-8049(22)00859-0

DO - 10.1016/S0959-8049(22)00859-0

M3 - Meeting Abstract

AN - SCOPUS:85140487899

VL - 174

SP - S21

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -